BRCA1 and BRCA2 genes play a crucial role in repairing damaged DNA. Mutations in BRCA1 and BRCA2 substantially increase the likelihood of breast and ovarian cancer, respectively. This new research ...

Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for ...

Allarity Therapeutics, Inc. ("Allarity” or the "Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical ...

This comprehensive review revealed compelling evidence for stenoparib’s durable clinical benefit in platinum-resistant, advanced ovarian cancer patients ... resistant human cancer cell lines, ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window 6.9% of ...

The peritoneum is a layer of thin tissue that lines the inside of the tummy (abdomen ... ovarian cancer at the same time as a separate womb (endometrial) cancer. Clear cell ovarian cancer can also be ...

Innovative diagnostic approaches: Serum protein markers in renal cell carcinoma. Comprehensive proteomic profiling of plasma samples associated with response or resistance to immune checkpoint ...

ADCs have transformed bladder cancer treatment ... “ADCs also engage with the immune system and promote immunogenic cell death via the antibody and also the payload activity.” ...

Deeper knowledge of the biology of ovarian cancer has led to the identification of multiple molecular targets, such as growth factor receptors, signal transduction pathways, cell cycle regulators ...